Monarch Partners Asset Management LLC Quanterix Corp Transaction History

Monarch Partners Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$15.06 - $30.65 $748,813 - $1.52 Million	-49,722 Reduced 41.37%	70,475 $1.14 Million
Q1 2022 May 06, 2022	BUY	$23.26 - $42.41 $1.69 Million - $3.09 Million	72,767 Added 153.42%	120,197 $3.51 Million
Q4 2021 Feb 03, 2022	SELL	$37.54 - $57.51 $3.99 Million - $6.12 Million	-106,345 Reduced 69.16%	47,430 $2.01 Million
Q3 2021 Nov 04, 2021	BUY	$45.91 - $59.67 $827,895 - $1.08 Million	18,033 Added 13.28%	153,775 $7.66 Million
Q2 2021 Jul 30, 2021	BUY	$43.3 - $67.17 $5.19 Million - $8.05 Million	119,872 Added 755.34%	135,742 $7.96 Million
Q1 2021 May 11, 2021	SELL	$44.11 - $90.64 $269,291 - $553,357	-6,105 Reduced 27.78%	15,870 $928,000
Q4 2020 Feb 04, 2021	SELL	$33.89 - $49.88 $309,076 - $454,905	-9,120 Reduced 29.33%	21,975 $1.02 Million
Q3 2020 Nov 05, 2020	BUY	$26.91 - $37.47 $269,638 - $375,449	10,020 Added 47.54%	31,095 $1.05 Million
Q2 2020 Jul 31, 2020	BUY	$19.21 - $28.53 $404,850 - $601,269	21,075 New	21,075 $577,000

158

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $354M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monarch Partners Asset Management LLC with notifications on news.